某医院活血化瘀类中成药临床应用的调查及分析

Investigation and Analysis of Clinical Application of Chinese Patent Medicine for Promoting Blood Circulation and Removing Blood Stasis in a Hospital

目的:分析我院活血化瘀类中成药临床应用的使用现状,为临床合理用药提供依据。方法:根据我院2018年临床使用活血化瘀类中成药的数据,将我院活血化瘀类中成药进行分类,收集我院2018年活血化瘀类中成药处方,分析开具该类处方的医师结构,并依据国家标准和相关中医药知识对其合理性进行点评;从而对活血化瘀类中成药在我院的使用现状作分析。结果:活血化瘀类中成药处方合理率为81.29%,主要为用法用量不正确、超禁忌用药、联合用药不适宜,分别占总不合理处方的53.49%、24.55%、14.83%。结论:应进一步加强不合理处方干预,提高医师、药师合理用药水平,保证患者用药安全。

Objective:To analyze the current situation of clinical application of Chinese patent medicines for promoting blood circulation and removing blood stasis in our hospital to provide a basis for the rational use of clinical medicine.Methods:According to the data of clinical use of Chinese medicines for promoting blood circulation and removing blood stasis in our hospital in 2018,the Chinese medicines for promoting blood circulation and removing blood stasis were classified,the prescriptions for Chinese medicine for promoting blood circulation and stasis were collected in our hospital,and the structure of the doctors who issued such prescriptions was analyzed according to national standards and relevant knowledge of Chinese medicine to evaluate its rationality.Then analyzed the current status of the use of Chinese patent medicines for promoting blood circulation and removing blood stasis in our hospital.Results:The reasonable rate of prescriptions for promoting blood circulation and removing blood stasis is 81.29%,mainly due to incorrect usage and dosage,over taboo medication,and unsuitable combination,accounting for 53.49%,24.55%and 14.83%of the total unreasonable prescriptions respectively.Conclusions:Unreasonable prescription intervention should be further strengthened to increase the level of reasonable medication used by physicians and pharmacists to ensure the safety of patients’medication.